FDA Lifts Block On Three Pliva Drugs

LONDON, July 7 (Reuters) - Croatian generic drugmaker Pliva, at the centre of a bid battle, said on Friday U.S. regulators had given a green light to three of its drugs after problems were fixed at production facilities in Zagreb.